Import Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings from Canada
Import trade data for Indian businesses
🇨🇦 Canada — Country Profile
Capital
Ottawa
GDP (USD)
$2K
Population
39.6M
Currency
Canadian Dollar
Trade Agreement
No preferential agreement
Import Snapshot
India imported $26.4M of medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings from Canada in 2024 — +3755.8% YoY.
Based on HS Code 3004 import data (UN Comtrade)
Import History — Canada to India
2024
$26.4M
HS 3004 imports
2023
$685K
HS 3004 imports
2022
$8.4M
HS 3004 imports
About Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings Imports from Canada
Canada is one of the supplying countries for medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings to the Indian market, classified under HS heading 3004. Indian importers source this product for domestic consumption, manufacturing inputs, or re-export.
Other Countries Supplying Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings to India
Import Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings from Canada
Get expert guidance on sourcing, customs procedures, and compliance.
Contact XIMPEX